Related Experiment Video
Updated: Apr 5, 2026
05:12
Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
Published on: September 4, 2017
11.4K
Molecular diagnosis in cerebral cavernous malformations.
1Servicio de Biología Molecular, UGC Bioquímica Clínica, Hospital Universitario Virgen Macarena, Sevilla, España.
Neurologia (Barcelona, Spain)
|August 26, 2015
Summary
Molecular diagnosis for cerebral cavernous malformations (CCMs) requires analyzing CCM genes for mutations. This review explores current techniques and alternatives for detecting genetic variations in CCM patients, especially when initial tests are negative.
Area of Science:
- Genetics
- Molecular Biology
- Neurology
Background:
- Cerebral cavernous malformations (CCMs) are vascular abnormalities affecting 0.1-0.5% of the population.
- Familial CCM is an autosomal dominant condition with variable penetrance.
- Mutations in CCM1, CCM2, and CCM3 genes are implicated in CCM development.
Purpose of the Study:
- To review current molecular diagnostic techniques for CCMs.
- To identify potential mutations and variations detectable in genetic laboratories.
- To explore alternative methods for mutation detection in negative cases.
Main Methods:
- Analysis of current molecular genetics and molecular biology techniques.
- Review of mutation detection strategies for CCM-associated genes.
- Exploration of alternative diagnostic approaches for challenging cases.
Main Results:
- A significant percentage of CCM cases lack detectable etiological mutations with current methods.
- Sequencing and copy number variation analysis of CCM genes are essential for molecular diagnosis.
- Alternative strategies are needed to improve mutation detection rates.
Conclusions:
- Molecular diagnosis of CCMs should include sequencing and copy number variation analysis of CCM genes.
- Genetic counseling is vital for patient and family support.
- Further research into novel detection methods is warranted for negative cases.
